Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A new twist?

smike6790

posted on Nov 19, 2008 06:02PM

RE: "any CEO worth his salt would be outraged at the action of the PPS"

When this Qs earnings are reported in January the TTM EPS will be

.02 + 0 + .01 + x =

Plug in your estimate of this Qs EPS (x) and add'm up. (We've had 2 license sales)

Then multiply that TTM EPS by, let's say 10.

Doing this gives me a calcualted PPS of approximately what we have closed at today.

The CEO knows this better than we do.







Share
New Message
Please login to post a reply